A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
Clinical trial NCT03888105 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03888105
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2026-06-17
- Enrollment
- 515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.